Be part of the knowledge - Prova Education

Medical News

medicalxpress.com
08/10/2022
Medical News
Study Finds Second Primary Lung Cancer Is 4% & as High as 8% Among Surgery Pati…
Read more
medicalxpress.com
08/10/2022
Medical News
ACL Reconstruction Goes Under the Microscope
Read more
prnewswire.com
08/10/2022
Medical News
There's a Better Way to Detect High-Risk Medications in Older Adults with Cance…
Read more

Popular

- Shaji K. Kumar, MD
  Peer
- María-Victoria Mateos, MD, PhD
  Peer
0
CME/CE
Multiple Myeloma: Updates from ASCO 2022
Multiple Myeloma: Updates from ASCO 2022
0.25 credits
Multiple Myeloma: Updates from ASCO 2022
0.25 credits
- Monique Hartley-Brown, MD, MMSc
  Peer
- Shonali Midha, MD
  Peer
1
CME/CE
Keeping Pace in Hematologic Malignancies: Newly Diagnosed Multiple Myeloma
Keeping Pace in Hematologic Malignancies: Newly Diagnosed Multiple Myeloma
0.25 credits
Keeping Pace in Hematologic Malignancies: Newly Diagnosed Multiple Myeloma
0.25 credits
- Cesar Rodriquez Valdes, MD
  Peer
- Amrita Krishnan, MD
  Peer
3
CME/CE
Keeping Pace in Hematologic Malignancies: Novel Targets for Multiple Myeloma
Keeping Pace in Hematologic Malignancies: Novel Targets for Multiple Myeloma
0.25 credits
Keeping Pace in Hematologic Malignancies: Novel Targets for Multiple Myeloma
0.25 credits
- Susan O’Brien, MD
  Peer
- Timothy Call, MD
  Peer
1
CME/CE
State of the Union: A Targeted Approach in First-Line Treatment of CLL/SLL
State of the Union: A Targeted Approach in First-Line Treatment of CLL/SLL
0.25 credits
State of the Union: A Targeted Approach in First-Line Treatment of CLL/SLL
0.25 credits
- Jacob D. Soumerai, MD
  Peer
- Andrew H. Lipsky, MD
  Peer
2
CME/CE
Optimizing Outcomes for Patients with Relapsed or Refractory CLL/SLL
Optimizing Outcomes for Patients with Relapsed or Refractory CLL/SLL
0.25 credits
Optimizing Outcomes for Patients with Relapsed or Refractory CLL/SLL
0.25 credits
- Elizabeth Smyth, MD
  Peer
- Jaffer Ajani, MD
  Peer
4
CME/CE
Optimal Standards of Care for Second-Line HER2-Positive Advanced Gastric and GEJ Cancers
Optimal Standards of Care for Second-Line HER2-Positive Advanced Gastric and GEJ Cancers
0.25 credits
Optimal Standards of Care for Second-Line HER2-Positive Advanced Gastric and GE…
0.25 credits
- Avni P. Finn, MD, MBA
  Peer
- Jayanth Sridhar, MD
  Peer
1
CME/CE
New Perspectives on Managing Diabetic Retinopathy
New Perspectives on Managing Diabetic Retinopathy
0.25 credits
New Perspectives on Managing Diabetic Retinopathy
0.25 credits
- Rajendra Apte, MD, PhD
  Peer
- Jennifer I. Lim, MD, FARVO
  Peer
- Adrienne W. Scott, MD
  Peer
0
CME/CE
New Treatment Strategies for Diabetic Retinopathy: Sharpening the Focus
New Treatment Strategies for Diabetic Retinopathy: Sharpening the Focus
0.25 credits
New Treatment Strategies for Diabetic Retinopathy: Sharpening the Focus
0.25 credits

CME/CE

- Shaji K. Kumar, MD
  Peer
- María-Victoria Mateos, MD, PhD
  Peer
1
CME/CE
Keeping Pace in Hematologic Malignancies: Updates from ASCO 2022
Keeping Pace in Hematologic Malignancies: Updates from ASCO 2022
0.25 credits
Keeping Pace in Hematologic Malignancies: Updates from ASCO 2022
0.25 credits
- Amrita Krishnan, MD
  Peer
- Morie Gertz, MD, MACP
  Peer
2
CME/CE
Keeping Pace in Hematologic Malignancies: Optimizing Treatment Selection in Relapsed or Refractory Multiple Myeloma
Keeping Pace in Hematologic Malignancies: Optimizing Treatment Selection in Relapsed or Refractory Multiple Myeloma
0.25 credits
Keeping Pace in Hematologic Malignancies: Optimizing Treatment Selection in Rel…
0.25 credits
- Carolyn E. Majcher, OD, FAAO
  Peer
- Diana Shechtman, OD, FAAO
  Peer
1
CME/CE
New Strategies for Managing Diabetic Retinopathy
New Strategies for Managing Diabetic Retinopathy
0.25 credits
New Strategies for Managing Diabetic Retinopathy
0.25 credits
- Richard Elion, MD
  Peer
4
CME/CE
Best Practices for Taking a Sexual History: Destigmatizing PrEP Care
Best Practices for Taking a Sexual History: Destigmatizing PrEP Care
0.25 credits
Best Practices for Taking a Sexual History: Destigmatizing PrEP Care
0.25 credits
- Lyudmila Bazhenova, MD
  Peer
- Benjamin Levy, MD
  Peer
7
CME/CE
The Emerging Role of HER2 (ERBB2) Mutations in NSCLC
The Emerging Role of HER2 (ERBB2) Mutations in NSCLC
0.25 credits
The Emerging Role of HER2 (ERBB2) Mutations in NSCLC
0.25 credits
- Amer Zeidan, MBBS
  Peer
- Amy E. DeZern, MD, MHS
  Peer
3
CME/CE
Managing and Monitoring MDS: MDS-Related Effects and Progression to AML
Managing and Monitoring MDS: MDS-Related Effects and Progression to AML
0.25 credits
Managing and Monitoring MDS: MDS-Related Effects and Progression to AML
0.25 credits

Clinical Practice

- Mark Socinski, MD
  Peer
- Jennifer Marie Suga, MD, MPH
  Peer
0
CME/CE
Personalizing NSCLC: The Optimal Applicability of NGS and Liquid Biopsy
Personalizing NSCLC: The Optimal Applicability of NGS and Liquid Biopsy
0.25 credits
Personalizing NSCLC: The Optimal Applicability of NGS and Liquid Biopsy
0.25 credits
- Caitlin Costello, MD
  Peer
0
Prova Oncology
Patients as Partners in Multiple Myeloma: What to Ask and What to Expect
Patients as Partners in Multiple Myeloma: What to Ask and What to Expect
Patients as Partners in Multiple Myeloma: What to Ask and What to Expect
- Sagar Lonial, MD
  Peer
- Noopur Raje, MD
  Peer
2
CME/CE
Novel Clinical Approaches in Multiple Myeloma: CAR T Cell Therapy
Novel Clinical Approaches in Multiple Myeloma: CAR T Cell Therapy
0.25 credits
Novel Clinical Approaches in Multiple Myeloma: CAR T Cell Therapy
0.25 credits
- Richard S. Isaacson, MD
  Peer
- Michael Weiner, MD
  Peer
4
CME/CE
Alzheimer’s Disease: Tools for Early Diagnosis
Alzheimer’s Disease: Tools for Early Diagnosis
0.25 credits
Alzheimer’s Disease: Tools for Early Diagnosis
0.25 credits
- David A. Wohl, MD
  Peer
- Lisa Hightow-Weidman, MD, MPH
  Peer
14
CME/CE
Having Productive Conversations with Patients at High Risk for HIV
Having Productive Conversations with Patients at High Risk for HIV
0.25 credits
Having Productive Conversations with Patients at High Risk for HIV
0.25 credits
- Diana Do, MD
  Peer
- John A. Wells, III, MD
  Peer
3
CME/CE
The Future Is Now: New Data for nAMD and DME in Vascular Integrity
The Future Is Now: New Data for nAMD and DME in Vascular Integrity
0.25 credits
The Future Is Now: New Data for nAMD and DME in Vascular Integrity
0.25 credits

Programs

- Ian W. Flinn, MD, PhD
  Peer
- William Wierda, MD
  Peer
1
CME/CE
Tackling Adverse Events Associated with Disruption of B-Cell Receptor Signaling: A Multispecialty Approach
Tackling Adverse Events Associated with Disruption of B-Cell Receptor Signaling: A Multispecialty Approach
0.25 credits
Tackling Adverse Events Associated with Disruption of B-Cell Receptor Signaling…
0.25 credits
- Susan B. Bressler, MD
  Peer
- Mark Dunbar, OD, FAAO
  Peer
- Ruth S. Weinstock, MD, PhD
  Peer
1
CME/CE
Saving Sight in Your Patients with Diabetes: What You Might Be Missing
Saving Sight in Your Patients with Diabetes: What You Might Be Missing
0.25 credits
Saving Sight in Your Patients with Diabetes: What You Might Be Missing
0.25 credits
- Neal Bhatia, MD
  Peer
- Jeffrey Sugarman, MD, PhD
  Peer
2
CME/CE
Rethinking the Use of Benzoyl Peroxide for Rosacea Treatment
Rethinking the Use of Benzoyl Peroxide for Rosacea Treatment
0.25 credits
Rethinking the Use of Benzoyl Peroxide for Rosacea Treatment
0.25 credits
- Jacqueline Garcia, MD
  Peer
- David A. Sallman, MD
  Peer
2
CME/CE
Keeping Pace with Hematologic Malignancies: Understanding, Classifying, and Stratifying MDS
Keeping Pace with Hematologic Malignancies: Understanding, Classifying, and Stratifying MDS
0.25 credits
Keeping Pace with Hematologic Malignancies: Understanding, Classifying, and Str…
0.25 credits
- Larry Anderson, MD, PhD
  Peer
- Thomas G. Martin, MD
  Peer
3
CME/CE
State of the Union: CAR T Cell Therapy
State of the Union: CAR T Cell Therapy
0.25 credits
State of the Union: CAR T Cell Therapy
0.25 credits
- Hilary Baldwin, MD
  Peer
- Linda Stein Gold, MD
  Peer
1
CME/CE
Update on the Benefits of a Microencapsulated Formulation of Benzoyl Peroxide and Tretinoin for Acne Treatment
Update on the Benefits of a Microencapsulated Formulation of Benzoyl Peroxide and Tretinoin for Acne Treatment
0.25 credits
Update on the Benefits of a Microencapsulated Formulation of Benzoyl Peroxide a…
0.25 credits